Table 1.
Subject | Hct | ctHb (g/dL) | T1a,in vivo (ms) | T1v,in vivo (ms) | fMetHb | T1a,in vitro (ms) | |
---|---|---|---|---|---|---|---|
1 | Female | 0.40 | 13.4 | 1876±19 | 1835±32 | 1.0% | 1851±19 |
2 | Female | 0.40 | 13.5 | 1921±41 | 1811±37 | 0.9% | 1825±41 |
3 | Female | 0.36 | 11.7 | 2037±26 | 1966±28 | 1.0% | 1990±26 |
4 | Female | 0.44 | 14.8 | 1854±28 | 1760±35 | 0.9% | 1927±28 |
5 | Female | 0.38 | 12.9 | 1820±30 | 1749±27 | 1.0% | 1910±30 |
6 | Female | 0.39 | 12.8 | 1937±53 | 1862±70 | 1.1% | 1906±53 |
| |||||||
7 | Male | 0.47 | 15.9 | 1720±26 | 1685±34 | 0.6% | 1730±26 |
8 | Male | 0.45 | 15.6 | 1804±61 | 1771±17 | 1.1% | 1806±61 |
9 | Male | 0.44 | 14.6 | 1811±30 | 1727±37 | 1.0% | 1797±30 |
10 | Male | 0.47 | 16.3 | 1725±41 | 1672±15 | ||
11 | Male | 0.41 | 13.4 | 1880±17 | 1846±18 | ||
12 | Male | 0.46 | 15.7 | 1789±24 | 1730±8 | ||
13 | Male | 0.43 | 14.4 | 1766±21 | 1792±13 | ||
| |||||||
Female Mean±SD | 0.39±0.03 | 13.2±1.0 | 1908±77 | 1831±79 | 1.0±0.1% | 1902±58 | |
| |||||||
Male Mean±SD | 0.45±0.02 | 15.1±1.0 | 1785±55 | 1746±61 | 0.9±0.3% | 1778±41 | |
| |||||||
Total Mean±SD | 0.42±0.04 | 14.2±1.4 | 1841±89 | 1785±80 | 1.0±0.2% | 1860±80 |